Margaret Tempero

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Astellas Pharma Global Development Inc.
    Topic:
    DSMC
    Date added:
    08/07/2024
    Date updated:
    08/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    AstraZeneca
    Topic:
    Consultant
    Date added:
    08/07/2024
    Date updated:
    08/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Bio Ascend-B2ACT Therapeutics Genex
    Topic:
    Consultant
    Date added:
    08/07/2024
    Date updated:
    08/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    BeiGene
    Topic:
    Advisory Board
    Date added:
    08/07/2024
    Date updated:
    08/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Biotech Research
    Topic:
    Advisory Board
    Date added:
    08/07/2024
    Date updated:
    08/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    BioSapiens
    Topic:
    Consultant
    Date added:
    08/07/2024
    Date updated:
    08/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Blueprint
    Date added:
    08/07/2024
    Date updated:
    08/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Boehringer Ingelheim
    Topic:
    Advisory Board
    Date added:
    08/07/2024
    Date updated:
    08/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    ElmediX
    Topic:
    Consultant
    Date added:
    08/07/2024
    Date updated:
    08/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Exact Sciences
    Topic:
    Scientific Advisor
    Date added:
    08/07/2024
    Date updated:
    08/07/2024

Pages

Return to 4th Binaytara Precision Oncology Summit: Current Standards and Emerging Therapies